Autoimmune retinopathy

From WikiMD's Medical Encyclopedia

Revision as of 19:14, 22 March 2025 by Prab (talk | contribs) (CSV import)

A rare autoimmune disease affecting the retina


Autoimmune retinopathy (AIR) is a rare autoimmune disease characterized by the immune system mistakenly attacking the retina, the light-sensitive tissue at the back of the eye. This condition can lead to progressive vision loss and is often associated with other systemic autoimmune disorders.

Pathophysiology

Autoimmune retinopathy occurs when the body's immune system produces antibodies that target and damage retinal cells. The exact mechanism is not fully understood, but it is believed that these antibodies interfere with normal retinal function, leading to cell death and subsequent vision impairment. The condition is often associated with the presence of anti-retinal antibodies (ARAs), which can be detected through specialized blood tests.

Symptoms

The symptoms of autoimmune retinopathy can vary but typically include:

These symptoms can progress over time, leading to significant visual impairment.

Diagnosis

Diagnosing autoimmune retinopathy can be challenging due to its rarity and the overlap of symptoms with other retinal diseases. A comprehensive ophthalmic examination is essential, which may include:

Treatment

Treatment for autoimmune retinopathy aims to suppress the immune response and preserve vision. Common approaches include:

The effectiveness of treatment varies, and early intervention is crucial to prevent irreversible vision loss.

Prognosis

The prognosis for individuals with autoimmune retinopathy depends on the severity of the disease and the response to treatment. Early diagnosis and management are key to preserving vision and preventing further retinal damage.

Related pages

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.